Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

FDC Ltd

NSE: FDC · BSE: 531599 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹329.60
Market cap
₹5,366 Cr
Revenue (annual)
₹2,171 Cr
Net profit (annual)
₹281.4 Cr
P/E (TTM)
18.3×Sector 47.4×
Promoter holding
69.66%+0.00% QoQ
FII holding
1.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:59 IST NSE
Annual General Meeting

FDC Annual General Meeting

FDC Limited issued a corrigendum to its 86th AGM notice, correcting the e-voting cut-off date to September 17, 2026. This also updates the book closure dates.

09:31 IST BSE
Promoter Selling (Off-Market)

FDC Promoter Selling (Off-Market)

Promoter Nandan Mohan Chandavarkar gifted 50,30,086 shares of FDC Ltd via off-market inter-se transfers. His personal stake decreased from 3.10% to 0.01%.

20:41 IST BSE
Business Update

FDC Business Update

FDC Limited submitted its Business Responsibility and Sustainability Report for the financial year 2025-26. This filing complies with regulation 34 of SEBI (LODR) regulations.

18:40 IST BSE
Annual Report

FDC Annual Report

FDC Limited has filed its Annual Report for the financial year 2025-26, and the 86th AGM is scheduled for September 24, 2026.

17:51 IST NSE
Annual General Meeting

FDC Annual General Meeting

FDC Limited issued a notice for its 86th Annual General Meeting to be held on September 24, 2026. The meeting includes agenda items for financial statement adoption.

16:12 IST NSE
Annual General Meeting

FDC Annual General Meeting

FDC Limited has scheduled its 86th Annual General Meeting for September 24, 2026, to approve financial statements and ratify the cost auditor's remuneration.

Value
₹0.04 Cr
17:31 IST BSE
Legal & Regulatory

FDC Legal & Regulatory

FDC Limited received an interim stay from the Delhi High Court regarding an FSSAI notice, allowing 8 months to exhaust existing stock with specific product labels.

14:23 IST BSE
Regulatory Approval

FDC Regulatory Approval

FDC Limited's subsidiary, FDC International Limited, received marketing authorization from MHRA, UK for Atropine 1.0% eye drops. This regulatory approval enables product commercialization in the United Kingdom.

18:03 IST BSE
Results Update

FDC Results Update

FDC Limited reported its Q1 FY27 consolidated results in a press release. The company highlighted Revenue of Rs. 668 crore and PAT of Rs. 132 crore.

15:09 IST NSE
Board Meeting Date

FDC Board Meeting Date

FDC Limited scheduled a board meeting for August 5, 2026. The board will consider the quarterly unaudited financial results for June 2026.